循環器ジャーナル66巻4号

2018年10月発行

特集 循環器救急の最前線—初期診療と循環管理を極める Ⅳ．循環管理を極める

循環作動薬の使い方

著者： 安部晴彦¹ 上田恭敬¹

所属機関： ¹国立病院機構大阪医療センター循環器内科

ページ範囲：P.562 - P.567

Point
・病態を正しく把握することによって，血管収縮薬，強心薬，血管拡張薬を適切に使い分けることができる．
・肺動脈カテーテルから得られる情報は，カテコラミンの用量調節に根拠を与えてくれる．
・カテコラミン抵抗性ショックを念頭に置く．

参考文献

1) Mebazaa A, Tolppanen H, Mueller C, et al:Acute heart failure and cardiogenic shock:a multidisciplinary practical guidance. Intensive Care Med 42:147-163, 2016

2) Ricard JD, Salomon L, Boyer A, et al:Central or peripheral catheters for initial venous access of ICU patients:a randomized controlled trial. Crti Care Med 41:2108-2115, 2013

3) Sato N, Kajimoto K, Keida T, et al:Clinical features and outcome in hospitalized heart failure in Japan（from the ATTEND Registry）. Circ J 77:944-951, 2013

4) Binanay C, Califf RM, Hasselblad V, et al:Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness:the ESCAPE trial. JAMA 294:1625-1633, 2005

5) Johnston IG, Jane R, Fraser JF, et al:Survey of intensive care nurses' knowledge relating to the pulmonary artery catheter. Anaesth Intensive Care 32:564-568, 2004

6) Pulmonary artery catheter study group, Iberti TJ, Fischer EP, et al:A multicenter study of physician's knowledge of the pulmonary artery catheter. JAMA 264:2928-2932, 1990

7) Swan HJ:The pulmonary artery catheter in anesthesia practice. Anesthesiology 103:890-893, 2005

8) Overgaard CB, Dzavik V:Inotropes and vasopressors.:review of physiology and clinical use in cardiovascular disease. Circulation 118:1047-1056, 2008

9) Bellomo R, Wan L, May C, et al:Vasoactive drugs and acute kidney injury. Crit Care Med 36:S179-186, 2008

10) Bellomo R, giantomasso DD:Noradrenaline and the kidney:friends or foes? Crit Care 5:294-298, 2001

11) De Backer D, Biston P, Devrient J, et al:Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779-789, 2010

12) Publication Committee for the VMAC Investigators:Intravenous nesiritide vs nitroglycerin for trwatment of decompensated congestive heart failure:a randomized controlled trial. JAMA 287:1531-1540, 2002

13) O'Conner CM, Starling RC, Hernandez AF, et al:Effect of Nesiritide in Patients with Acute Decompensated Heart Failure. N Engl J Med 365:32-43, 2011

14) Chen HH, Anstrom KJ, Givertz MM, et al:Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction:the ROSE acute heart failure randomized trial. JAMA 310:2533-2543, 2013

15) Hata N, Seino Y, Tsutamoto T, et al:Effects of carperitide on the long term prognosis of patients with acute decompensated chronic heart failure. -The PROTECT multicenter randomized controlled study-Circ J 72:1787-1793, 2008

16) Sezai A, Hata M, Niino T, et al:Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting:the NU-HIT trial for CKD. J Am Coll Cardiol 58:897-903, 2011

17) Moriyama T, Hagihara S, Shiramoto T, et al:The protective effect of human atrial natriuretic peptide on renal damage during cardiac surgery. J Anesth 31:163-169, 2017

18) Elkayam U, Ng TM, Hatamizadeh P, et al:Renal vasodilatory action of dopamine in patients with heart failure:magnitude of effect and site of action. Circulation 117:200-205, 2008

19) Kamiya M, Sato N, Akiya M, et al:A case of marked diuresis by combined dopamine and atrial natriuretic peptide administration without renal injury in acute decompensated heart failure. Int Heart J 54:243-245, 2013

20) Kamiya M, Sato N, Nozaki A, et al:Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide. J Cardiovasc Pharmacol 65:282-288, 2015

21) Lowes BD, Tsvetkova T, Eichhorn EJ, et al:Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 81:141-149, 2001

22) Cuffe MS, Califf RM, Adams KF Jr, et al:Short-term intravenous milrinone for acute exacerbation of chronic heart failure:arandomized controlled trial. JAMA 287:1541-1547, 2002

23) Watanabe H, Kajimoto K, Hagiwara N, et al:Acute efficacy of combined PDE-Ⅲ-inhibitor and low dose dobutamine therapy in patients with acute exacerbation of chronic heart failure receiving β blocker. J Cardiol Jpn Ed1:148-154, 2008